The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

LIVE MARKETS-Europe in the black spurred by oil stocks

Tue, 24th Nov 2020 08:46

* European STOXX 600 index up 0.6%

* Oil and gas stocks lead gains up 2.9%
Welcome to the home for real-time coverage of markets brought to
you by Reuters reporters. You can share your thoughts with us at
markets.research@thomsonreuters.com

EUROPE IN THE BLACK SPURRED BY OIL STOCKS (0843 GMT)

European stocks are higher as investors expect a strong
economic recovery in 2021 due to vaccine progress, ignoring a
batch of results showing the damage of the coronavirus crisis.

Reports that Joe Biden’s pick for the Treasury Secretary is
former Fed Chair Janet Yellen is seen as a confirmation that the
top priority of the new administration will be on stimulus.

The STOXX 600 index is up 0.8% with oil and gas
stocks, today up 2.8%, leading gains for the second day
in a row as Brent crude prices hit their highest levels since
March on hopes of a quicker recovery in oil demand.

Shares in Novartis are outperforming their peers,
up 1.7%, after the company said it is initiating a previously
announced share buyback worth up to $2.5 billion.

British Airways owner IAG stocks continue to
outperform, today up 6%, on hopes of an easing in the
restrictive measures after news of effective vaccines.

Helping BA shares, England said it will introduce a new
system on Dec. 15, allowing the use of testing to shorten
quarantine for incoming passengers.

(Stefano Rebaudo)

*****

ON THE RADAR: VIRUS DAMAGES, CREDIT SUISSE, NOVARTIS (0744
GMT)

European stocks are set to open higher, still wary but
willing to look at the bright side after vaccine progress which
allows to hope in a strong economic recovery in 2021.

While the outlook is improving, several companies still
have to strengthen their balance sheets to repair damages from
the coronavirus crisis.

Greencore plans to raise cash by issuing new shares,
after it reported an 81% plunge in annual profit.

JD Sports is in exclusive talks with British
department store chain Debenhams over a potential rescue
takeover, The Times reported.

Compass Group reported a 75.5% slump in annual
pretax profit.

Deutz stocks are down 9.6% in pre-market trade
after the company postponed its medium-term targets of achieving
revenue of 2 billion euros and operating profit margin of 7%-8%
to 2023/24 from 2022.

Shares in Sixt are down 4.4% trade after the
company announced its new 2020 financial outlook.

It is a whole different story on the pharma front. Novartis
is initiating a previously announced share buyback
worth up to $2.5 billion, while it increased its target for a
technical operations productivity programme starting in 2021 to
$2 billion from $1.5 billion and said it was committed to
driving constant margin expansion.

Shares in Idorsia are up 3.6% in pre-market trade,
after the company announced positive results of two Japanese
registration studies with clazosentan.

Eyes also on Credit Suisse after the Swiss bank
said it expects to take a roughly $450 million impairment on its
stake in alternative investment firm York Capital Management.

Telcos are still busy with their network, with KPN
accelerating investment to 3.5 billion euros over the next three
years , while Italy told top utility Enel
it must bear in mind in any sale of its stake in broadband group
Open Fiber that plans to create a national ultra-fast network
are a matter of urgency and cannot be delayed.

Meanwhile Aryzta said that Elliott Capitol Advisors
had amended its potential takeover offer for an indicative price
of 0.80 Swiss francs per share.

(Stefano Rebaudo)

*****

EUROPE IN THE BLACK, LOOKS AT THE BRIGHT SIDE (0628 GMT)

European stocks are in positive territory as markets today
seem willing to look at the bright side on progress made on the
coronavirus vaccine while Joe Biden is about to start the
hand-over process with the White House.

Worries about the impact of lockdowns on the economy
continue to weigh in the continent after data showing business
activity contracted sharply in November, while in the U.S. IHS
Markit's indexes topped forecast staying comfortably above
water.

Rotation was under way as the Dow Jones outperformed the
tech-heavy Nasdaq.

Reports that Biden’s pick for the U.S. Treasury Secretary
role was former Fed Chair Janet Yellen was well-received as it
confirms fiscal stimulus will definitely be on the table of the
new administration.

(Stefano Rebaudo)

*****

Related Shares

More News
4 Mar 2024 08:59

LONDON BROKER RATINGS: Jefferies says buy BP; UBS says buy Compass

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

4 Mar 2024 07:41

LONDON BRIEFING: Stocks called down; attention on UK's spring budget

(Alliance News) - Stocks in London are called to open lower, ahead of a busy week of economic news.

22 Feb 2024 14:23

UK dividends calendar - next 7 days

12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.